How Do Breast Implants Affect Your Cancer Screening? (And What VeriScan Is)

A great question came in — and one I had recently been at a lecture with a radiologist about, so the timing was perfect to share what I learned.

The big-picture answer: breast implants do not, in real-world data, meaningfully worsen breast cancer outcomes when patients are getting appropriate screening. But there are some technical considerations that matter — and a new technology you may not have heard of yet that could change how implant patients get imaged.

Let me walk through it.

Whenever someone has breast augmentation, there's a longstanding theoretical concern:

• An implant in the breast can physically block some of the underlying breast tissue from being seen on a mammogram
• This is most relevant for over-the-muscle (subglandular or subfascial) placements
• In that placement, the implant sits directly behind the breast tissue, potentially obscuring small amounts of tissue along its back wall

The theoretical worry has been that over-the-muscle implants might lead to harder-to-detect cancers, possibly diagnosed at a more advanced stage.

Here's the reassuring part: the theoretical concern hasn't played out in real-world outcomes.

Studies over the years have looked at:

• Implant placement (under-muscle vs. over-muscle)
• Incision location
• Implant volume
• Other technical factors

What they've found:

• Women with over-the-muscle implants have not been shown to be diagnosed with later-stage cancers
• They have not been shown to have higher rates of "missed" cancers
• Their cancer outcomes are broadly comparable to women with under-the-muscle implants and to women without implants

So while the theoretical concern about tissue visibility behind an implant is real, the practical impact on cancer detection hasn't materialized in the data we have.

That said, there's a nuance that matters.

This was the most useful part of the radiologist's lecture for me. It is the radiologist's job to look at the mammogram and determine if they can adequately see everything they need to see.

If the radiologist can't see what they need to see — because of implant position, tissue density, or any other factor — they should recommend additional imaging:

• Ultrasound
• MRI

This is where the system depends on the radiologist actually being thoughtful about implant patients, rather than just reading the mammogram and signing off.

This is the part I want every implant patient to absorb:

Practical steps:

This should happen automatically when you book your mammogram, but don't assume. Tell the technician. Tell the radiologist if you see them. Note it in your patient portal.

There's a technique called Eklund displacement views where the technician pushes the implant out of the way to image more of the breast tissue. Make sure your mammogram facility does these for implant patients — and that they're being captured.

After your mammogram, it's reasonable to circle back with the doctor who ordered the imaging and ask:

• "Was the radiologist able to see everything they needed to see?"
• "Are any additional images recommended?"
• "Should I be doing ultrasound or MRI in addition?"

This is not over-asking. As an implant patient, this is the level of engagement I'd want you to have with your screening.

If you have dense breasts and implants, adding an ultrasound to your annual mammogram is often a smart call. The combination gives you better coverage of breast tissue that may be partially obscured by both density and the implant.

This is a separate but important thread: silicone implants need imaging surveillance for integrity — ultrasound or MRI starting at year 5 of implant life, every 1–2 years thereafter. This is distinct from breast cancer screening and serves a different purpose.

This was the part of the lecture I was most excited about.

VeriScan is a relatively new technology — a breast CT scan. It's different from a traditional CT in a few important ways:

• It's a CT scan dedicated to breast imaging, not whole-body
• It does a better job seeing under the implant than mammography
• It still picks up microcalcifications similar to mammography (the early calcifications associated with the earliest breast cancers)
• It does not require compression of the breast
• It does not require Eklund displacement views

For implant patients in particular, this is potentially big — it eliminates two of the more frustrating aspects of mammography (compression and the displacement maneuvers) while still capturing the calcification data that makes mammography so valuable.

• It is not FDA-cleared as a screening modality
• It is currently used as a diagnostic modality (when a problem is already suspected)
• It may eventually become a useful screening option for implant patients, but we're not quite there yet from a regulatory standpoint

I think this is worth knowing about because it's the kind of technology that may meaningfully change implant patient screening in the next few years. If your radiologist offers it as a follow-up to a routine mammogram and you have implants, it's a reasonable option to consider.

I want to be direct: breasts like to make cancer. That's the unfortunate truth. Even with implants, even with good screening protocols, even with everything done right — breast cancer is common and showing up earlier in women's lives than it did decades ago.

For patients who have made the decision to have implants, your screening just needs to be slightly more thoughtful than the average patient's:

• Make sure you're telling your facility you have implants
• Make sure your radiologist can see what they need to see
• Don't miss your annual mammogram
• Consider adding ultrasound if you have dense tissue
• Don't conflate breast cancer screening with implant integrity surveillance — they're separate
• And please don't skip mammograms because of misinformation about radiation or "toxins" — mammograms genuinely save lives

Breast implants do not, in real-world data, lead to worse breast cancer outcomes when patients receive appropriate screening. The theoretical concern about tissue visibility behind implants hasn't played out as a meaningful problem.

What does matter is that your radiologist is engaged with the fact that you have implants and recommends additional imaging (ultrasound or MRI) if they can't see what they need to see. Ask the question. Don't just assume.

And keep an eye on VeriScan as a potentially better option for implant patients in the coming years. The technology is improving — and for those of us who care about both breast augmentation outcomes and breast cancer screening, the trajectory is genuinely encouraging.